Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis

ObjectivesThe spectrum of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) represents highly inflammatory rheumatic diseases. Patients mostly report severe physical impairment. Possible consequences for mental health have been scarcely studied. The aim of this study was to investigate psy...

Full description

Bibliographic Details
Main Authors: Matthias Froehlich, Antonia Zahner, Marc Schmalzing, Michael Gernert, Patrick-Pascal Strunz, Sebastian Hueper, Jan Portegys, Eva Christina Schwaneck, Ottar Gadeholt, Andrea Kübler, Johannes Hewig, Philipp Ziebell
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1146815/full
_version_ 1797816587056578560
author Matthias Froehlich
Antonia Zahner
Marc Schmalzing
Michael Gernert
Patrick-Pascal Strunz
Sebastian Hueper
Jan Portegys
Eva Christina Schwaneck
Ottar Gadeholt
Andrea Kübler
Johannes Hewig
Philipp Ziebell
author_facet Matthias Froehlich
Antonia Zahner
Marc Schmalzing
Michael Gernert
Patrick-Pascal Strunz
Sebastian Hueper
Jan Portegys
Eva Christina Schwaneck
Ottar Gadeholt
Andrea Kübler
Johannes Hewig
Philipp Ziebell
author_sort Matthias Froehlich
collection DOAJ
description ObjectivesThe spectrum of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) represents highly inflammatory rheumatic diseases. Patients mostly report severe physical impairment. Possible consequences for mental health have been scarcely studied. The aim of this study was to investigate psychological well-being in the context of GCA and PMR.MethodsCross-sectional study with N = 100 patients with GCA and/or PMR (GCA-PMR). Patient-reported outcomes (PROs) were measured using the Short Form 36 Version 2 (SF-36v2) and visual analog scale (VAS) assessment. Moreover, the Patient Health Questionnaire 9 (PHQ-9) was used in 35 of 100 patients to detect depression. To compare PROs with physician assessment, VAS was also rated from physician perspective. To assess a possible association with inflammation itself, serological parameters of inflammation (C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) were included.ResultsIn all scales of the SF-36v2 except General Health (GH) and in the physical and mental sum score (PCS, MCS), a significant impairment compared to the German reference collective was evident (MCS: d = 0.533, p < 0.001). In the PHQ-9 categorization, 14 of the 35 (40%) showed evidence of major depression disorder. VAS Patient correlated significantly with PHQ-9 and SF-36 in all categories, while VAS Physician showed only correlations to physical categories and not in the mental dimensions. Regarding inflammatory parameters, linear regression showed CRP to be a complementary significant positive predictor of mental health subscale score, independent of pain.ConclusionPRO show a relevant impairment of mental health up to symptoms of major depression disorder. The degree of depressive symptoms is also distinctly associated with the serological inflammatory marker CRP.
first_indexed 2024-03-13T08:39:50Z
format Article
id doaj.art-3abcbc0a6e2943879000aa7738db2404
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-03-13T08:39:50Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-3abcbc0a6e2943879000aa7738db24042023-05-30T14:04:22ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-05-011010.3389/fmed.2023.11468151146815Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritisMatthias Froehlich0Antonia Zahner1Marc Schmalzing2Michael Gernert3Patrick-Pascal Strunz4Sebastian Hueper5Jan Portegys6Eva Christina Schwaneck7Ottar Gadeholt8Andrea Kübler9Johannes Hewig10Philipp Ziebell11Department of Internal Medicine II, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, GermanyDepartment of Psychology I, Institute of Psychology, University of Würzburg, Würzburg, GermanyDepartment of Internal Medicine II, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, GermanyDepartment of Internal Medicine II, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, GermanyDepartment of Internal Medicine II, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, GermanyDepartment of Internal Medicine II, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, GermanyDepartment of Internal Medicine II, Rheumatology/Clinical Immunology, University Hospital Würzburg, Würzburg, GermanyMVZ Rheumatologie und Autoimmunmedizin, Hamburg, GermanyRheumatologische Schwerpunktpraxis Würzburg, Würzburg, GermanyDepartment of Psychology I, Institute of Psychology, University of Würzburg, Würzburg, GermanyDepartment of Psychology I, Institute of Psychology, University of Würzburg, Würzburg, GermanyDepartment of Psychology I, Institute of Psychology, University of Würzburg, Würzburg, GermanyObjectivesThe spectrum of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) represents highly inflammatory rheumatic diseases. Patients mostly report severe physical impairment. Possible consequences for mental health have been scarcely studied. The aim of this study was to investigate psychological well-being in the context of GCA and PMR.MethodsCross-sectional study with N = 100 patients with GCA and/or PMR (GCA-PMR). Patient-reported outcomes (PROs) were measured using the Short Form 36 Version 2 (SF-36v2) and visual analog scale (VAS) assessment. Moreover, the Patient Health Questionnaire 9 (PHQ-9) was used in 35 of 100 patients to detect depression. To compare PROs with physician assessment, VAS was also rated from physician perspective. To assess a possible association with inflammation itself, serological parameters of inflammation (C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) were included.ResultsIn all scales of the SF-36v2 except General Health (GH) and in the physical and mental sum score (PCS, MCS), a significant impairment compared to the German reference collective was evident (MCS: d = 0.533, p < 0.001). In the PHQ-9 categorization, 14 of the 35 (40%) showed evidence of major depression disorder. VAS Patient correlated significantly with PHQ-9 and SF-36 in all categories, while VAS Physician showed only correlations to physical categories and not in the mental dimensions. Regarding inflammatory parameters, linear regression showed CRP to be a complementary significant positive predictor of mental health subscale score, independent of pain.ConclusionPRO show a relevant impairment of mental health up to symptoms of major depression disorder. The degree of depressive symptoms is also distinctly associated with the serological inflammatory marker CRP.https://www.frontiersin.org/articles/10.3389/fmed.2023.1146815/fullgiant cell arteritisPROdepressionmental impairmentSF-36PHQ-9
spellingShingle Matthias Froehlich
Antonia Zahner
Marc Schmalzing
Michael Gernert
Patrick-Pascal Strunz
Sebastian Hueper
Jan Portegys
Eva Christina Schwaneck
Ottar Gadeholt
Andrea Kübler
Johannes Hewig
Philipp Ziebell
Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
Frontiers in Medicine
giant cell arteritis
PRO
depression
mental impairment
SF-36
PHQ-9
title Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
title_full Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
title_fullStr Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
title_full_unstemmed Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
title_short Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
title_sort patient reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
topic giant cell arteritis
PRO
depression
mental impairment
SF-36
PHQ-9
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1146815/full
work_keys_str_mv AT matthiasfroehlich patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT antoniazahner patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT marcschmalzing patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT michaelgernert patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT patrickpascalstrunz patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT sebastianhueper patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT janportegys patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT evachristinaschwaneck patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT ottargadeholt patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT andreakubler patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT johanneshewig patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis
AT philippziebell patientreportedoutcomesprovideevidenceforincreaseddepressivesymptomsandincreasedmentalimpairmentingiantcellarteritis